EGFR and non-small cell lung carcinoma: The in vivo imaging of fluorescently labeled P6-FITC in a side-by-side xenograft model of H1299/K562 (EGFR+/EGFR− cell lines, respectively) resulted in specific intra-tumoral accumulation of P6-FITC in EGFR+ NSCLC tumors.